These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24499768)

  • 21. Value of Kleihauer testing after administration of anti-D immunoglobulin.
    Duguid JK; Bromilow I
    BMJ; 1994 Jul; 309(6949):240. PubMed ID: 8069142
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 23. Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee.
    Mark A; Foster AM; Grossman D; Prager SW; Reeves M; Velásquez CV; Winikoff B
    Contraception; 2019 May; 99(5):265-266. PubMed ID: 30867121
    [No Abstract]   [Full Text] [Related]  

  • 24. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
    Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
    Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
    [No Abstract]   [Full Text] [Related]  

  • 25. Kleihauer testing. Many cases of sensitisation may be avoidable.
    Murphy WG; Ghosh S; Hughes RH; Craig JI; Greer IA
    BMJ; 1994 Sep; 309(6957):806. PubMed ID: 7848430
    [No Abstract]   [Full Text] [Related]  

  • 26. Kleihauer testing. Need not be abandoned.
    Love EM; Shwe KH
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950581
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biological markers: what changes with prophylaxis?].
    Mannessier L
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S9-11. PubMed ID: 18228706
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-D administration in early pregnancy--time for a new protocol.
    Carmody F
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
    Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing Rh immunisation.
    Letsky EA; de Silva M
    BMJ; 1994 Jul; 309(6949):213-4. PubMed ID: 7848416
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
    Chauhan AR; Bhattacharyya MS; Turakhia N; Daftary GV
    J Assoc Physicians India; 2002 Oct; 50():1341-2. PubMed ID: 12568238
    [No Abstract]   [Full Text] [Related]  

  • 32. More on Rhogam.
    Keutzer B
    Midwifery Today Int Midwife; 2000; (56):68-9; author reply 69. PubMed ID: 11984911
    [No Abstract]   [Full Text] [Related]  

  • 33. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
    [No Abstract]   [Full Text] [Related]  

  • 34. Rhogam: do midwives hold the evidence?
    Wickham S
    Midwifery Today Int Midwife; 1998; (46):34-5. PubMed ID: 10338629
    [No Abstract]   [Full Text] [Related]  

  • 35. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C; Wray J
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419
    [No Abstract]   [Full Text] [Related]  

  • 36. Kleihauer testing. Quality assurance scheme exists.
    Urbaniak SJ; Main R; Fraser N
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950582
    [No Abstract]   [Full Text] [Related]  

  • 37. Rhesus isoimmunization.
    Plevyak MP; Carr SR
    Med Health R I; 2001 May; 84(5):148-51. PubMed ID: 11392951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization].
    College National de Gynecolegues et Obstetriciens Francais
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839
    [No Abstract]   [Full Text] [Related]  

  • 39. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
    Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
    BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-D. Part 2: Risks and benefits.
    Wickham S
    Pract Midwife; 1999 Jun; 2(6):38-9. PubMed ID: 10481677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.